Effect of folic acid supplementation on the folate status of buccal mucosa and lymphocytes

G P Basten, M H Hill, Susan Joyce Duthie, H J Powers

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    Folate deficiency may be associated with an increased risk of cancer at certain sites. There is a need to measure folate status and putative biomarkers of cancer risk in the same target tissue, or in surrogate tissues. A study was carried out to develop a method for the rapid measurement of folate in human buccal mucosa and lymphocytes and to evaluate the responsiveness of this measurement in both tissues to folic acid supplementation in healthy subjects, relative to conventional markers of folate status. Three hundred and twenty-three adults, ages between 20 and 60 years, were screened for RBC folate concentrations. Sixty-five subjects with red cell folate between 200 and 650 nmol/L participated in a randomized, double blind, placebo-controlled, folic acid (1.2 mg) intervention trial, lasting 12 weeks. As anticipated, a significant baseline correlation (r = 0.36, P < 0.01) was observed between red cell folate and plasma 5-methyltetrahydrofolate (5-MeTHF). Lymphocyte total folate was significantly associated with plasma 5-MeTHF (r = 0.28, P < 0.05) and plasma total homocysteine concentration (r = -0.34, P < 0.05). Buccal mucosa total folate showed no correlation with either red cell folate or 5-MeTHF, but was significantly associated with lymphocyte total folate (r = 0.35, P < 0.01). Supplementation elicited a significant increase in lymphocyte total folate (P < 0.01), and this was strongly associated with the increase in RBC total folate (P < 0.01) and plasma 5-MeTHF (P < 0.01). Buccal mucosa total folate was not influenced by folate supplementation. Methods have been developed for the rapid measurement of lymphocyte and buccal mucosal total folate. Lymphocyte folate is sensitive to folate intake and is reflected by plasma 5-MeTHF.

    Original languageEnglish
    Pages (from-to)1244-1249
    Number of pages6
    JournalCancer Epidemiology, Biomarkers and Prevention
    Volume13
    Issue number7
    Publication statusPublished - Jul 2004

    Keywords

    • methylenetetrahydrofolate-reductase gene
    • plasma folate
    • uracil misincorporation
    • cervical dysplasia
    • controlled-trial
    • DNA instability
    • long-term
    • in-vitro
    • deficinecy
    • cancer
    • Folate
    • supplementation
    • lymphocyte total folate
    • buccal mucosal folate
    • red cell folate
    • 5-methyltetrahydrofolate
    • homocysteine

    Cite this

    Effect of folic acid supplementation on the folate status of buccal mucosa and lymphocytes. / Basten, G P ; Hill, M H ; Duthie, Susan Joyce; Powers, H J .

    In: Cancer Epidemiology, Biomarkers and Prevention, Vol. 13, No. 7, 07.2004, p. 1244-1249.

    Research output: Contribution to journalArticle

    Basten, G P ; Hill, M H ; Duthie, Susan Joyce ; Powers, H J . / Effect of folic acid supplementation on the folate status of buccal mucosa and lymphocytes. In: Cancer Epidemiology, Biomarkers and Prevention. 2004 ; Vol. 13, No. 7. pp. 1244-1249.
    @article{50c5bad5e52d4d1eb98cb0458b41725b,
    title = "Effect of folic acid supplementation on the folate status of buccal mucosa and lymphocytes",
    abstract = "Folate deficiency may be associated with an increased risk of cancer at certain sites. There is a need to measure folate status and putative biomarkers of cancer risk in the same target tissue, or in surrogate tissues. A study was carried out to develop a method for the rapid measurement of folate in human buccal mucosa and lymphocytes and to evaluate the responsiveness of this measurement in both tissues to folic acid supplementation in healthy subjects, relative to conventional markers of folate status. Three hundred and twenty-three adults, ages between 20 and 60 years, were screened for RBC folate concentrations. Sixty-five subjects with red cell folate between 200 and 650 nmol/L participated in a randomized, double blind, placebo-controlled, folic acid (1.2 mg) intervention trial, lasting 12 weeks. As anticipated, a significant baseline correlation (r = 0.36, P < 0.01) was observed between red cell folate and plasma 5-methyltetrahydrofolate (5-MeTHF). Lymphocyte total folate was significantly associated with plasma 5-MeTHF (r = 0.28, P < 0.05) and plasma total homocysteine concentration (r = -0.34, P < 0.05). Buccal mucosa total folate showed no correlation with either red cell folate or 5-MeTHF, but was significantly associated with lymphocyte total folate (r = 0.35, P < 0.01). Supplementation elicited a significant increase in lymphocyte total folate (P < 0.01), and this was strongly associated with the increase in RBC total folate (P < 0.01) and plasma 5-MeTHF (P < 0.01). Buccal mucosa total folate was not influenced by folate supplementation. Methods have been developed for the rapid measurement of lymphocyte and buccal mucosal total folate. Lymphocyte folate is sensitive to folate intake and is reflected by plasma 5-MeTHF.",
    keywords = "methylenetetrahydrofolate-reductase gene, plasma folate, uracil misincorporation, cervical dysplasia, controlled-trial, DNA instability, long-term, in-vitro, deficinecy, cancer, Folate, supplementation, lymphocyte total folate, buccal mucosal folate, red cell folate, 5-methyltetrahydrofolate, homocysteine",
    author = "Basten, {G P} and Hill, {M H} and Duthie, {Susan Joyce} and Powers, {H J}",
    year = "2004",
    month = "7",
    language = "English",
    volume = "13",
    pages = "1244--1249",
    journal = "Cancer Epidemiology, Biomarkers and Prevention",
    issn = "1055-9965",
    publisher = "AMER ASSOC CANCER RESEARCH",
    number = "7",

    }

    TY - JOUR

    T1 - Effect of folic acid supplementation on the folate status of buccal mucosa and lymphocytes

    AU - Basten, G P

    AU - Hill, M H

    AU - Duthie, Susan Joyce

    AU - Powers, H J

    PY - 2004/7

    Y1 - 2004/7

    N2 - Folate deficiency may be associated with an increased risk of cancer at certain sites. There is a need to measure folate status and putative biomarkers of cancer risk in the same target tissue, or in surrogate tissues. A study was carried out to develop a method for the rapid measurement of folate in human buccal mucosa and lymphocytes and to evaluate the responsiveness of this measurement in both tissues to folic acid supplementation in healthy subjects, relative to conventional markers of folate status. Three hundred and twenty-three adults, ages between 20 and 60 years, were screened for RBC folate concentrations. Sixty-five subjects with red cell folate between 200 and 650 nmol/L participated in a randomized, double blind, placebo-controlled, folic acid (1.2 mg) intervention trial, lasting 12 weeks. As anticipated, a significant baseline correlation (r = 0.36, P < 0.01) was observed between red cell folate and plasma 5-methyltetrahydrofolate (5-MeTHF). Lymphocyte total folate was significantly associated with plasma 5-MeTHF (r = 0.28, P < 0.05) and plasma total homocysteine concentration (r = -0.34, P < 0.05). Buccal mucosa total folate showed no correlation with either red cell folate or 5-MeTHF, but was significantly associated with lymphocyte total folate (r = 0.35, P < 0.01). Supplementation elicited a significant increase in lymphocyte total folate (P < 0.01), and this was strongly associated with the increase in RBC total folate (P < 0.01) and plasma 5-MeTHF (P < 0.01). Buccal mucosa total folate was not influenced by folate supplementation. Methods have been developed for the rapid measurement of lymphocyte and buccal mucosal total folate. Lymphocyte folate is sensitive to folate intake and is reflected by plasma 5-MeTHF.

    AB - Folate deficiency may be associated with an increased risk of cancer at certain sites. There is a need to measure folate status and putative biomarkers of cancer risk in the same target tissue, or in surrogate tissues. A study was carried out to develop a method for the rapid measurement of folate in human buccal mucosa and lymphocytes and to evaluate the responsiveness of this measurement in both tissues to folic acid supplementation in healthy subjects, relative to conventional markers of folate status. Three hundred and twenty-three adults, ages between 20 and 60 years, were screened for RBC folate concentrations. Sixty-five subjects with red cell folate between 200 and 650 nmol/L participated in a randomized, double blind, placebo-controlled, folic acid (1.2 mg) intervention trial, lasting 12 weeks. As anticipated, a significant baseline correlation (r = 0.36, P < 0.01) was observed between red cell folate and plasma 5-methyltetrahydrofolate (5-MeTHF). Lymphocyte total folate was significantly associated with plasma 5-MeTHF (r = 0.28, P < 0.05) and plasma total homocysteine concentration (r = -0.34, P < 0.05). Buccal mucosa total folate showed no correlation with either red cell folate or 5-MeTHF, but was significantly associated with lymphocyte total folate (r = 0.35, P < 0.01). Supplementation elicited a significant increase in lymphocyte total folate (P < 0.01), and this was strongly associated with the increase in RBC total folate (P < 0.01) and plasma 5-MeTHF (P < 0.01). Buccal mucosa total folate was not influenced by folate supplementation. Methods have been developed for the rapid measurement of lymphocyte and buccal mucosal total folate. Lymphocyte folate is sensitive to folate intake and is reflected by plasma 5-MeTHF.

    KW - methylenetetrahydrofolate-reductase gene

    KW - plasma folate

    KW - uracil misincorporation

    KW - cervical dysplasia

    KW - controlled-trial

    KW - DNA instability

    KW - long-term

    KW - in-vitro

    KW - deficinecy

    KW - cancer

    KW - Folate

    KW - supplementation

    KW - lymphocyte total folate

    KW - buccal mucosal folate

    KW - red cell folate

    KW - 5-methyltetrahydrofolate

    KW - homocysteine

    M3 - Article

    VL - 13

    SP - 1244

    EP - 1249

    JO - Cancer Epidemiology, Biomarkers and Prevention

    JF - Cancer Epidemiology, Biomarkers and Prevention

    SN - 1055-9965

    IS - 7

    ER -